The GLP is committed to full transparency. Download and review our just-released 2019 Annual Report.

As European Court ponders regulatory fate of CRISPR and other New Breeding Techniques, anti-biotechnology groups lobby for GMO-like restrictions

| July 16, 2018

There is a burning debate in Europe about the future of GMO regulation. The [European Court of Justice] will announce a landmark ruling on July 25. If seed companies get their way, [new breeding techniques] such as CRISPR / Cas9 could be exempted from regulation.

To protect human health and the environment, the genetic engineering regulations prescribe preventive measures. They thus follow the so-called precautionary principle: Potential damage to the environment and health should be avoided in advance.

If the [new breeding techniques] are not regulated like genetic engineering, genetically modified plants will come onto the market without risk assessment and labeling. There are then:

  • no mandatory risk assessment for humans and the environment,
  • no labeling of genetically modified products,
  • no mandatory safety measures to prevent contamination of non-GMO products,
  • and no possibility to temporarily restrict or prohibit the use of the product in case of danger to health or the environment.

 

Editor’s note: This article was originally published in German. This English summary has been prepared with Google Translate and lightly edited for clarity.

Read full, original article: Regulate new genetic engineering methods

The GLP aggregated and excerpted this article to reflect the diversity of news, opinion, and analysis. Click the link above to read the full, original article.
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend